NO20032491D0 - Krystallinsk glukosamin sulfat metall salter - Google Patents

Krystallinsk glukosamin sulfat metall salter

Info

Publication number
NO20032491D0
NO20032491D0 NO20032491A NO20032491A NO20032491D0 NO 20032491 D0 NO20032491 D0 NO 20032491D0 NO 20032491 A NO20032491 A NO 20032491A NO 20032491 A NO20032491 A NO 20032491A NO 20032491 D0 NO20032491 D0 NO 20032491D0
Authority
NO
Norway
Prior art keywords
metal salts
crystalline glucosamine
novel crystalline
glucosamine sulphate
present
Prior art date
Application number
NO20032491A
Other languages
English (en)
Other versions
NO324847B1 (no
NO20032491L (no
Inventor
Triptikumar Mukhopadhyay
Ravi Gajanan Bhat
E S Sreekumar
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Publication of NO20032491D0 publication Critical patent/NO20032491D0/no
Publication of NO20032491L publication Critical patent/NO20032491L/no
Publication of NO324847B1 publication Critical patent/NO324847B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20032491A 2000-12-01 2003-06-02 Krystallinske glukosamin sulfat metall salter NO324847B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1088MU2000 2000-12-01
IN1087MU2000 2000-12-01
IN394MU2001 2001-04-26
PCT/IN2001/000211 WO2002043653A2 (en) 2000-12-01 2001-12-03 Crystalline glucosamine sulphate metal salts

Publications (3)

Publication Number Publication Date
NO20032491D0 true NO20032491D0 (no) 2003-06-02
NO20032491L NO20032491L (no) 2003-07-30
NO324847B1 NO324847B1 (no) 2007-12-17

Family

ID=27272463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032491A NO324847B1 (no) 2000-12-01 2003-06-02 Krystallinske glukosamin sulfat metall salter

Country Status (29)

Country Link
US (1) US6812223B2 (no)
EP (1) EP1347986B1 (no)
JP (1) JP4307072B2 (no)
KR (1) KR100842400B1 (no)
CN (1) CN100351261C (no)
AT (1) ATE293122T1 (no)
AU (2) AU2002217416B2 (no)
BG (1) BG107845A (no)
BR (1) BR0115801A (no)
CA (1) CA2436925C (no)
CZ (1) CZ20031503A3 (no)
DE (1) DE60110118T2 (no)
DK (1) DK1347986T3 (no)
DZ (1) DZ3450A1 (no)
EA (1) EA006632B1 (no)
ES (1) ES2240570T3 (no)
HR (1) HRP20030400A2 (no)
HU (1) HU229546B1 (no)
IL (2) IL156100A0 (no)
MA (1) MA25925A1 (no)
MX (1) MXPA03004693A (no)
NO (1) NO324847B1 (no)
NZ (1) NZ526079A (no)
PL (1) PL207740B1 (no)
PT (1) PT1347986E (no)
RO (1) RO121738B1 (no)
SI (1) SI21188A (no)
SK (1) SK285926B6 (no)
WO (1) WO2002043653A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012818A1 (it) * 2001-12-28 2003-06-28 Acraf Un metodo per preparare un composto della glucosammina e composto cosi ottenuto
JP2006508643A (ja) 2002-07-01 2006-03-16 アーキオン ライフ サイエンシーズ エルエルシー ディー/ビー/エー バイオ−テクニカル リソーセズ ディビジョン グルコサミンおよびn−アセチルグルコサミン製造のためのプロセスおよび材料
US7388001B1 (en) 2004-09-17 2008-06-17 Jfc Technolries, Llc Halide-free glucosamine sulfate compositions and methods of preparation
US7683042B1 (en) 2004-09-17 2010-03-23 Jfc Technologies, Llc Stabilized halide-free glucosamine base and method of preparation
US7388000B1 (en) 2004-09-17 2008-06-17 Jfct Technologies, Llc Halide-free glucosamine phosphate compositions and methods of preparation
US7622576B1 (en) 2004-09-22 2009-11-24 Jfc Technologies, Llc Halide-free glucosamine base and method of preparation
DE102005033844A1 (de) * 2005-07-20 2007-02-01 Beiersdorf Ag Insektenabwehrmittel mit Langzeitwirkung
US7854956B2 (en) * 2007-03-07 2010-12-21 Exportadora De Sal, S.A. De C.V. Low sodium salt compositions and methods of preparation and uses thereof
CN101735283B (zh) * 2008-11-14 2012-07-18 徐州海吉亚生物制品有限公司 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术
CA2779168A1 (en) * 2009-11-05 2011-05-12 Pharma Base India Pvt. Ltd. Process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride
CN106866751B (zh) * 2017-02-17 2019-11-05 江苏双林海洋生物药业有限公司 一种硫酸氨基葡萄糖复盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148050B (it) * 1981-04-30 1986-11-26 Rotta Research Lab Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
CH690719A5 (it) * 1996-08-19 2000-12-29 Rotta Res B V Amsterdam Swiss Procedimento per la preparazione di sali misti della glucosamina.
US5843923A (en) * 1998-05-22 1998-12-01 Jame Fine Chemicals, Inc. Glucosamine sulfate potassium chloride and process of preparation thereof

Also Published As

Publication number Publication date
WO2002043653A3 (en) 2003-01-03
EA006632B1 (ru) 2006-02-24
IL156100A (en) 2009-09-01
PL207740B1 (pl) 2011-01-31
NZ526079A (en) 2005-07-29
PT1347986E (pt) 2005-08-31
PL366386A1 (en) 2005-01-24
RO121738B1 (ro) 2008-03-28
ATE293122T1 (de) 2005-04-15
KR20030055336A (ko) 2003-07-02
CZ20031503A3 (cs) 2003-10-15
CA2436925A1 (en) 2002-06-06
WO2002043653A2 (en) 2002-06-06
CN100351261C (zh) 2007-11-28
KR100842400B1 (ko) 2008-07-01
SK6482003A3 (en) 2003-09-11
MXPA03004693A (es) 2005-04-19
BG107845A (bg) 2004-08-31
NO324847B1 (no) 2007-12-17
HU229546B1 (hu) 2014-01-28
EP1347986A4 (en) 2004-01-21
SI21188A (sl) 2003-10-31
DE60110118D1 (de) 2005-05-19
MA25925A1 (fr) 2003-10-01
SK285926B6 (sk) 2007-11-02
BR0115801A (pt) 2005-12-13
US20040030121A1 (en) 2004-02-12
DK1347986T3 (da) 2005-08-15
WO2002043653B1 (en) 2003-05-22
DE60110118T2 (de) 2006-03-02
US6812223B2 (en) 2004-11-02
AU1741602A (en) 2002-06-11
NO20032491L (no) 2003-07-30
EP1347986B1 (en) 2005-04-13
JP2004529860A (ja) 2004-09-30
AU2002217416B2 (en) 2007-02-08
JP4307072B2 (ja) 2009-08-05
DZ3450A1 (fr) 2002-06-06
HRP20030400A2 (en) 2005-10-31
EP1347986A2 (en) 2003-10-01
CN1479744A (zh) 2004-03-03
HUP0302154A3 (en) 2006-01-30
IL156100A0 (en) 2003-12-23
ES2240570T3 (es) 2005-10-16
CA2436925C (en) 2008-10-14
EA200300614A1 (ru) 2004-10-28
HUP0302154A2 (hu) 2003-10-28

Similar Documents

Publication Publication Date Title
NO20032491D0 (no) Krystallinsk glukosamin sulfat metall salter
NZ581390A (en) Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
BRPI0520050A2 (pt) composto, processo para a preparação de um composto e processo de glicosilação estereoseletiva para a preparação de mais de 99% de anÈmero b enriquecido de hidrocloreto de gencitabina
BR0308385A (pt) Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso
BR0317803A (pt) Derivados de benzamidas como inibidores de receptor p2x7 para o tratamento de doenças inflamatórias
BR112013020620A2 (pt) análogos de ácido 4-hidroxibutírico
TN2009000177A1 (en) Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
BR0209957A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende um composto, utilização desse composto e processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
SG170828A1 (en) Deazapurines useful as inhibitors of janus kinases
CA2288445A1 (en) 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
MA33838B1 (fr) Forme amorphe et cristalline de l'hémitartrate de genz 112638 au titre d'inhibiteur de la glucosylcéramide synthétase
TW200616967A (en) Novel indazole carboxamides and their use
UA88792C2 (ru) Гидроксибензоатные соли метаникотиновых соединений
PL1633376T3 (pl) Środki do profilaktyki i leczenia objawów przeziębienia i grypopodobnych zawierające chelatowany cynk
HRP20150949T1 (hr) UPORABA 24-norUDCA
EP2597083A3 (en) Selective hydroxamate based MMP inhibitors
BR9916270A (pt) Combinação de cerivastatina e fibratos
PL374896A1 (en) A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
LT2003051A (en) Crystalline glucosamine sulphate metal salts and process for preparing the same
WO2006015232A3 (en) Use of methyl pyruvate for the purpose of increasing muscle energy production
PL1951725T3 (pl) N-Sulfamoilo-N-benzopiranopiperydyny jako inhibitory anhydraz węglanowych
FR2849601B1 (fr) Nouvelles compositions synergiques de boissons stimulant le metabolisme cellulaire pour ameliorer l'efficacite des extraits de plantes
ECSP034670A (es) Sales de metal cristalinas de sulfato de glucosamina y procedimientos para su preparacion

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: PIRAMAL ENTERPRISES LTD, IN

MM1K Lapsed by not paying the annual fees